Erly Pen Injection (Liraglutide)
Description
Erly Pen Injection contains Liraglutide, a GLP-1 receptor agonist used for managing type 2 diabetes and aiding weight loss.
Uses:
✔ Type 2 Diabetes Mellitus – Helps lower blood sugar levels effectively.
✔ Weight Management – Approved for weight loss in obese and overweight individuals.
✔ Cardiovascular Risk Reduction – Reduces the risk of heart attack and stroke in diabetic patients.
How Erly Pen Works:
Liraglutide mimics the GLP-1 hormone, which regulates blood sugar and appetite. It slows digestion, increases insulin secretion, and reduces hunger, aiding both diabetes control and weight loss.
Common Side Effects:
🔹 Nausea
🔹 Vomiting
🔹 Diarrhea
🔹 Decreased appetite
🔹 Injection site reactions
Serious Side Effects (Seek Medical Help):
⚠️ Pancreatitis (severe abdominal pain)
⚠️ Thyroid tumors (rare but serious)
⚠️ Kidney issues (dehydration, low urine output)
⚠️ Gallbladder problems (severe stomach pain, yellowing of skin)
Precautions:
⚡ Pregnancy & Breastfeeding: Not recommended.
⚡ Thyroid Disease: Avoid if you have a history of thyroid tumors.
⚡ Kidney & Liver Conditions: Use with caution.
⚡ Avoid Alcohol: Can increase the risk of low blood sugar.
£ 65.00
